#healthier sg clinic

[health-and-medical-services]

Achieve Holistic Healthcare at Sengkang Clinic – Your Healthier SG Partner

Healthier SG Clinics are conceived to serve each of you better through more holistic care-from preventive services to proper treatment. Balancing prevention with effective treatment, Healthier SG Clinics service general consultations, vaccinations, or chronic disease management-to name just a few.

Find a Healthier SG Clinic nearby, check your eligibility, and book an appointment. With health-care experts and most modern facilities, these clinics are your trusted partners in health. Come visit Sengkang Clinic today at Blk 215C Compassvale Drive, Singapore 543215, or call 6385 0113 to embark on your healthier journey.

[asiamedic-astique]

Best Healthier SG Clinic In Singapore | AcuMed Holdings Pte Ltd

Are you looking for the best healthier SG clinic in Singapore? Are you exhausted by searching on Google and still your hands are empty? Then it is your day today if you are reading this post. Population Health includes Healthier SG as a "major reform of the healthcare system."

Choose AcuMed through healthier SG as your family doctor and establish a long-lasting, trustworthy relationship with us so that we can assist you on your path to better health.

[whattheabcxyz]

2024-10-28

Singapore

Ong Ye Kung says TCM could play a role in Healthier SG - MOH is exploring how to “carefully incorporate” certain TCM treatments into public clinics & hospitals, with patients able to get subsidies for such treatments

Fire breaks out at battery recycling plant in Tuas

HDB flat owner wins High Court case against contractor that shuttered firm before resolving dispute

16-year-old girl among 112 nabbed for suspected drug offences

Government adds another $440m in investment to boost growth of deep tech startups

Crowd & traffic management rules in Little India kick in for Deepavali period

Man accused of killing grassroots volunteer taken back to crime scene - this year alone, there have been 7 cases of murder or alleged murder here

Health

Woman has had to deal with 3 different cancers in the course of 28 years

Singapore: Flu shots available at 3 retail pharmacies from today - this is part of a trial to expand flu vaccination access in the community ...flu shots are useless & don't prevent you from getting the flu at all, & even if you take it, your symptoms could still be bad!

Food

Singapore: New app lets diners here buy unsold food at big discount, helping cut food waste - founded in 2020, the app is also available in Hong Kong & Thailand

Swiss woman in Singapore says Swiss restaurant Marche lacks authenticity - I really don't know what she was expecting 🙄

Entertainment

^ Transformers One is as good an origin story as it gets!

People

71-year-old Kenny Bee falls twice at band's Guangzhou concert - he's had so much plastic surgery over the years he looks like a freak

Travel

Tokyo-bound SIA flight diverted to Taipei due to cracked windshield

[singsys]

The Impact of Mobile Apps on Singapore’s Economy and Daily Life

In Singapore, mobile apps have transformed various sectors, driving economic growth and enhancing the quality of life. This blog explores the impact of mobile apps on Singapore’s economy and how they are reshaping sectors such as healthcare, education, retail, and transportation.

Transforming Healthcare

Mobile App Development Singapore have revolutionised the healthcare industry by improving accessibility, efficiency, and patient care. With the rise of telemedicine apps, patients can now consult with healthcare professionals remotely, reducing the need for physical visits to clinics or hospitals. Apps like Doctor Anywhere and MyDoc allow users to book virtual consultations, access medical records, and receive prescriptions online.

These apps not only enhance convenience for patients but also alleviate the burden on healthcare facilities. They enable healthcare providers to deliver timely care, especially during emergencies or pandemics. Furthermore, mobile health apps empower individuals to monitor their health and wellness through fitness trackers, diet planners, and mental health resources, promoting healthier lifestyles.

Revolutionising Education

The education sector in Singapore has witnessed a significant transformation with the integration of mobile apps. Educational apps like Edmodo, ClassDojo, and Khan Academy facilitate interactive and personalised learning experiences for students. These apps provide access to a vast array of educational resources, enabling students to learn at their own pace and according to their preferences.

Mobile apps also support educators by offering tools for lesson planning, student assessment, and classroom management. The COVID-19 pandemic accelerated the adoption of e-learning platforms, highlighting the importance of digital tools in ensuring uninterrupted education. As a result, Singaporean students are better equipped for the digital future, with access to quality education regardless of their location.

Enhancing Retail Experiences

The retail sector in Singapore has been transformed by mobile apps, which offer consumers convenient and personalised shopping experiences. E-commerce platforms like Lazada, Shopee, and Qoo10 have gained popularity, allowing users to browse and purchase products from the comfort of their homes. These apps provide features such as personalised recommendations, secure payment options, and efficient delivery services.

Retail apps also enable businesses to reach a broader audience, offering opportunities for small and medium-sized enterprises (SMEs) to compete with larger players. By leveraging data analytics and customer insights, retailers can tailor their offerings and marketing strategies to meet the evolving needs of consumers. As a result, the retail sector has become more dynamic and customer-centric, driving economic growth and innovation.

Transforming Transportation

Mobile apps have revolutionised transportation in Singapore, enhancing convenience, efficiency, and sustainability. Ride-hailing apps like Grab and Gojek have become integral to urban mobility, offering users on-demand transportation services with just a few taps on their smartphones. These apps provide options for carpooling, bike-sharing, and food delivery, contributing to a more integrated and flexible transportation ecosystem.

Public transportation apps like SG Bus and MRT Map offer real-time information on bus and train schedules, helping commuters plan their journeys more effectively. By promoting the use of public transportation and reducing reliance on private vehicles, these apps contribute to reducing traffic congestion and carbon emissions, supporting Singapore’s vision of becoming a sustainable and smart city.

Driving Economic Growth

The proliferation of Mobile App Development Singapore has significant economic implications. The mobile app industry generates revenue through app development, advertising, and in-app purchases, contributing to the country’s GDP. Additionally, mobile apps create employment opportunities for app developers, designers, marketers, and IT professionals.

The government’s support for digital innovation and entrepreneurship has fostered a thriving ecosystem for app development in Singapore. Initiatives such as the Smart Nation initiative and the Infocomm Media Development Authority’s (IMDA) programs encourage the growth of tech startups and the adoption of digital solutions across various sectors.

Mobile apps have had a profound impact on Singapore’s economy and daily life, transforming sectors such as healthcare, education, retail, and transportation. By enhancing accessibility, convenience, and efficiency, these apps have improved the quality of life for Singaporeans while driving economic growth and innovation. As Singapore continues to embrace digital transformation, Mobile App Development Singapore will play an increasingly vital role in shaping the country’s future, offering new opportunities for businesses and individuals alike.

[kirtiremedo]

Reliable Dental Care - Super-specialty Aesthetic and Implant Centre, Vasundhara

Reliable Dental Care - Vaundhara's Trusted Dental Clinic🌟 Expert Smile Makeovers 🌟 Implants 🌟 Clear Aligners 🌟Welcome to Reliable Dental Care, Vaundhara's premier dental clinic founded by Dr. Nitin Shishodia, MDS. Our award-winning clinic specializes in expert smile makeovers, advanced implant procedures, state-of-the-art clear aligner treatments.🏆 Recognized Excellence: With years of experience, our seasoned team of dental professionals is dedicated to providing top-notch dental care tailored to your unique needs.👨‍👩‍👧‍👦 Family-Friendly Atmosphere: Our warm and friendly environment ensures a comfortable experience for your entire family, from kids to adults. Your journey to a healthier, more radiant smile starts with us 9743641158

1209, Sector -3, Vasundhara opp. SG Homes, Near Adharsheela School Ghaziabad Uttar Pradesh 201012

nitinshishodia48@gmail.com

097436 41158

[blueweave]

Global Bioanalytical Testing Services Market Gaining Momentum—Projected to Reach Worth USD 5.1 Billion in 2027

A study recently conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027). Increasing awareness among the people regarding the benefits of bioanalytical testing services is driving the market growth. Additionally, the efficiency offered by outsourcing lab services as compared to conducting an in-house study is encouraging the outsourcing of such services, which is likely to boost the demand over the forecast period. Also, innovation or new molecule development is propelling the demand of the bioanalytical testing market.

Increased Number of Outsourcing Laboratories Service

Outsourcing lab projects provide several benefits such as financial and performance benefits, quality control, research, and improved product development services. Additionally, it leads to the commercialization of labs, which in turn benefits laboratory staff by helping them gain global career opportunities besides driving the growth of global bioanalytical testing services. Also, outsourcing laboratory services gives more time to public and government organizations to focus on other business aspects. Furthermore, these laboratory services are effective in providing more precise outcomes of the trials which further drive the overall global bioanalytical testing service market.

Rising Focus on the Analytical Testing of Biosimilars

According to a study published in 2017, there were 6·8 million cases of IBD globally. The age-standardized prevalence rate increased from 79·5 (75·9–83·5) per 100,000 population in 1990 to 84·3 (79·2–89·9) per 100 000 population in 2017. The main benefit of using biosimilar for patients with inflammatory bowel disease (IBD) is reduced drug acquisition costs. Biosimilars aren't generic drugs; they are almost similar to the original biologic agents—but, like generics, they're less expensive than the originals. Biosimilars are less costly than originator biologic agents primarily because biosimilars do not have to undergo the intensive clinical development process associated with the approval of an originator. Furthermore, biosimilars do not require high costs for marketing, market access, and postmarketing research and development. As a result, it allows for cost savings, which can then be passed on to customers and payers. The aforementioned are the key factors driving the growth of the global bioanalytical testing service.

Global Bioanalytical Testing Services Market: By Application

Based on application, the global bioanalytical testing services market is categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology caters to the largest share in the application segment in this market. This growth is primarily due to the increasing number of clinical trials conducted for oncology by government institutions and pharmaceutical companies, and the rising prevalence of cancer worldwide. With the increasing number of cancer cases worldwide, both government and private organizations are increasingly focusing on developing novel cancer therapies for the people.

According to The World Health Organization, there was a total of 19.3 million cancer cases in 2020. By 2040, the cases are likely to reach 30.2 million. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women. As a result, the demand for cancer therapies is witnessing an upward trend, which is further fueling the demand for bioanalytical testing services.

Download Free Sample Report: https://www.blueweaveconsulting.com/global-bioanalytical-testing-services-market/report-sample

Impact of COVID-19

Government authorities across the globe proposed stringent public health measures to restrict the virus's spread after COVID-19 was declared as a pandemic. Owing to the restrictive measures and lack of supplies, cancer research centers, cancer treatment hospitals and cancer organizations have seen their operations suffer significantly.

Thus, the global bioanalytical testing services saw a downfall in the market due to COVID-19. Moreover, limited access to clinics, combined with social distancing norms, and complete lockdown declared by several countries, resulted in a slow-down in patient flow and referral, which in turn has impacted the market growth. During the COVID-19 epidemic, cancer screenings fell sharply. Repeated screening for cervical cancer went down by 68% across the USA in the first 15 weeks of 2020, while breast cancer checking went down by 17%, with more significant declines in areas where the outbreak was sturdiest.

Global Bioanalytical Testing Services Market: Regional Insights

Geographically, the global bioanalytical testing services market is categorized into North America, Europe, the Asia-Pacific, the MiddleEast & Africa, and Latin America. The Asia-Pacific is likely to be the fastest-growing region over the forecast period owing to the increase in the number of a large pool of patients, especially in India and China. According to Asian Diabetic Initiative, 60% of diabetics in the world live in Asia. 113.9 million adults have diabetes in China which is 11.6% of the adult population. Also, 65.1 million adults in India has diabetes. The increasing number of diabetic patients is expected to increase the demand for bioanalysis of the novel (large molecule compounds) peptide therapeutics. Additionally, increased healthcare awareness, and the growing demand for early diagnosis of patients in the Asia-Pacific, along with a growth in outsourcing activities are driving the market growth.

Competitive Landscape

The bioanalytical testing services market's high growth potential has drawn a slew of new entrants, creating a lucrative opportunity. The emergence of new entrants has resulted in healthier competition among long-established service providers.

Some of the key players in the Global Bioanalytical Testing service market are Charles River Laboratories, Medpace, Wuxi Apptec, Eurofins Scientific, Iqvia Inc., Sgs Sa, Laboratory Corporation of America Holdings, Intertek Group Plc, Pra Health Sciences, Syneos Health, Icon Plc, Frontage Labs, and other prominent players. In order to improve their production capability, product portfolio, and provide competitive differentiation, companies are increasingly participating in acquisitions, alliances, and mergers.

On 17 February 2021, Charles River Laboratories announced the acquisition of Cognate BioServices, a premier cell and gene therapy contract development and manufacturing organization (CDMO), and Cobra Biologics, its gene therapy division. Charles River will become a leading science partner for cell and gene therapy advancement, testing, and manufacturing as a result of the proposed acquisition, offering clients an integrated solution from early research and discovery through CGMP processing.

Don’t miss the business opportunity of the global bioanalytical testing services market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global bioanalytical testing services market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the ­­­bioanalytical testing services market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

[ireviewuread]

New Generation Chemical Peel in Singapore Review

Trying out New Generation Chemical peels from Ekseption Medical

Chemical Peel, a technique used to improve and smooth the texture of the skin. If used correctly, chemical peels could even work better than laser treatments. Recently, I was invited by Xmedicimports to the aesthetic chemical peel training event held for aestheticians in Singapore to try out I was excited to attend the event, having the privilege to try out and experience the new generation peels from Ekseption medical.

Ekseption products are pharmaceutical grade and made in Spain. They are ISO certified and products are free from endotoxins which most products contain. Their strict filtration process are among the top in the industry where only 2 other manufacturers in the world match. These make Ekseption products a staple in many clinics internationally, even in leading beauty market like Korea. The chemical peel course was conducted by Xmedicimports Training Academy, the only authorised training academy for Ekseption medical in asia. 

During the event, I met two lovely bloggers featured in the photo - Serene of Xavvy-licious and  Sowmya of My Fusion World.

Aesthetic Chemical Peel Training Event by Xmedicimports | eKseption Aesthetics Training Asia

Aestheticians from various clinics and salon were trained to perform a detailed patient assessment, to understand the history and lifestyle of the patient and to examine their skin condition and to understand their concern. The group that I was assigned to was from Spa esprit.

The aestheticians were also taught in-depth on chemical peel types, the skin anatomy, the characteristic and strength of various acids, stages of skin wounding, proper patient evaluation and the proper selection of peels for different patient.

Chemical Peel Course Training Session

The training session continues with a demonstration from the trainer, she taught on the proper applicator tools to use for different consistency of the chemical acids and how to properly condition the skin for the peel. The application method and technique were also meticulously explained. She also touched on the pH for acids, neutralizer and products that are so important when performing a good chemical peel procedure. The aesthetician also learned on the techniques to perform different peels like oil-based, water-based, or alcohol-based peels which requires much different approach.    

There are so many different types of chemical peel suitable for people of different skin types. It is interesting to learn about most of them.

Types of chemical peel from Ekseption  Medical

Retinol peel - acne / sun damage /rough texture

White-up peptide peel - pigmentation and dark spots

Ageless peptide peel - fine and deep lines

Water infusion peel - dry skin

Couperix peel - rosacea , broken capillaries

Caviar peptide peel - rejuvenation

Pure skin peel - acne / oily skin with open pores

Ferulic peel - brightening and glow

Soft touch peel - sensitive skin

Cleansing our faces with Ekseption Salicylic Powder 

After the demonstration, it’s time for the aestheticians to practice on performing the peels

We had prepared our face cleansing with Ekseption Salicylic Powder cleanser. This facial foaming powder helps cleanse and exfoliate the skin at the same time, removing the dirt and grime and leaving the skin osft and breathable. It is also preservative, sulphate and PEG free, and have an excellent ecological profile.

This botanical-based brightening exfoliator without harsh ingredients helps brighten and even skin tone without chemical abrasives. The natural papaya enzymes work to eliminate dry, dull surface cells and toxins to reveal a soft and smooth complexion. This mild cleanser suits especially oily acne prone skin or skin that is prone to black and whiteheads. By using this cleanser, it improves the penetration of other treatment products due to the removal of dead surface cells.

Ekseption Salicylic Powder Cleanser

To use this, wet both hands and pour a dime size of powder in a hand. Rub hands together to transform it into a rich and creamy foam in your hands. Massage gently over face and neck for 30-60 seconds. Rinse with lukewarm water, pat dry with a soft towel. This cleanser is scentless and it helps stimulates cellular renewal, for brighter skin; Reduces skin pigmentation and; enlighten the skin tone.

I like how the cleanser is scentless and helps thoroughly remove my mild makeup from my sensitive skin without any skin irritation.

Ferulic Acid Peptide Peel

The ferulic acid peptide peel was performed on my sensitive skin. This superficial peel is used to treat skin ageing and neutralize free radicals. The peel was left for 3 minutes before it was neutralised with an Ekseption Hyaluronic carboxy neutraliser. It was a new experience for me. My skin reached a BOHR effect where I feel a fresh oxygenated sensation. After the peel, the Ekseption ice cream repair cream was applied to hydrate, repair and balance my skin. 

The unique thing about the Ferulic acid peptide peel is that although it is a strong anti-oxidant peel, it is gentle and non-drying, giving an immediate glow to the skin. Plus, Ferulic acid has photoprotective properties that help everyone including those that have pigmented skin. 

Chemical Peel Review - Ferulic Acid Peptide Peel

At first, I was worried about how the chemical peel would irritate my sensitive skin but it did not. The aestheticians from Spa Esprit Group have over 8 years of experience and they pick up the training fast from the trainer, a skin patch test was done to test for any immediate reaction prior to the actual peel. Overall the peel was very comfortable, it has no irritation or pain. We were also advised on the proper post peel care and the importance of sun protection post peel.

Chemical Peel Before 

Before the chemical peel process, my skin felt tight, looked dull and have slight redness on my cheeks. 

Chemical Peel After

After the chemical peel process, my skin looks hydrated it was glowing. I look so much healthier in general. The redness on my cheeks has also diminished. I do feel very moisturised afterwards.

Chemical Peel Before After

You can see the obvious difference before and after the Ferulic Acid Peptide Peel. My skin not only look fairer and feel smoother but it was also glowing. I enjoyed the process.

Certificate giving ceremony

At the end of the course, the trainees that have passed the exams are certified at the certificate giving ceremony. You can check out the interview on  Xmedicimports Facebook page where I interviewed some of these participants on their thoughts before and after the exam.

Ekeseption Medicial Aesthetic Training Academy SG 

Instagram | Facebook | Website

For clinic/salon training enquiry, please contact Xmedicimports at info@xmedicimports.com

Food from the Event

What’s an event without food? We were served a table filled with yummy sweets from brownies to macarons and tarts. The yummy, gooey brownies that melt in your mouth as you savoury its taste is from Tasty Delights. The sweet macarons with a creamy filling that is a favourite among the bloggers are from Jenna Macarons.

Tasty Delights SG 

Instagram | Facebook 

Jenna Macarons

Instagram | Facebook 

It was an eye opener for aestheticians to improve their knowledge and handling on chemical peels. Clinics and salons should really explore these new general peels out.

[bigyack-com]

Minor Hotels to Operate Clinique La Prairie's First Aesthetics and Medical Spa Outside of Europe

Minor Hotels has partnered with Clinique La Prairie to operate the Swiss health clinic's very first aesthetics and medical spa outside of Europe. Due to launch later this year, the Clinique La Prairie Aesthetics & Medical Spa will operate at The St. Regis Bangkok under MSpa International, the corporate division of spa and wellness within Minor Hotels. The St. Regis Bangkok is owned by Minor Hotels. The state-of-the-art medical spa will offer forever young treatments and healing therapies in line with Clinique La Prairie’s commitment to helping and inspiring people to live a healthier, longer and better life.

Simone Gibertoni, CEO of Clinique La Prairie, said, “Since 1931, Clinique La Prairie is a unique destination where the level of care enwraps the guests in cutting edge health care and wellness. After nearly 90 years of heritage in Switzerland, the clinic's ambition is to offer its expertise and its holistic approach to well-being - based on the four pillars of medical care, wellness, nutrition and exercise – abroad.” Slated to open in 2020, Bangkok’s Clinique La Prairie Aesthetics & Medical Spa will be located on the 15th floor of The St. Regis Bangkok. The facility will feature dedicated male and female relaxation areas, each spread over two floors with a relaxation lounge and floating pods, locker facilities, showers and restrooms on the mezzanine level, while the lower wet area of each showcase steam rooms, jacuzzis, cold plunge pools, and experience showers inviting personalized selection of water pressure, lighting and music. Zoe Wall, Group Director of MSpa International, said, “Clinique La Prairie is a global leader when it comes to longevity-based programs. The Clinique La Prairie Aesthetics & Medical Spa will bring a host of exclusive firsts to Bangkok. A team of medical spa professionals and aesthetics medicine specialists will combine expert knowledge with contemporary science and state-of-the-art technology to ensure bespoke experiences with a results-driven focus. Individual consultations to address longevity, beauty and nutrition will be available to guests in which they will receive a tailor-made program to enhance their lifestyle.” See latest Travel News, Interviews, Podcasts and other news regarding: Minor, Spa, Wellness. Headlines: Marriott Opens First Aloft Hotel in Bali, Indonesia  Thai Airways Cancels International Flights in Asia and Europe  Bangkok Airways Makes Major Changes to Domestic and Int. Flight Schedules  Air Astana Makes Changes to Int. Flight Schedules  Finnair to Increase Use of Sustainable Aviation Fuel  Airbus to Showcase A220, A350-900 and H145 at Wings India  Women's and Men's Rugby Africa Cup 2020 to Take Place at Same Time  Pictures from Miss International Queen 2020 in Pattaya, Thailand  IATA Updates Analysis of Financial Impact of COVID19 Outbreak  Capella Launches New Hotel Brand  15,000 Athletes Expected at Laguna Phuket Marathon 2020  Starlux Airlines Signs Distribution Agreement with Sabre  Korean Air Expands Temperature Checks to All Flights Departing Incheon  IDeaS Launches RevPlan  Singapore Airlines Cargo Renews CEIV Pharma Certification; Expands Network  Accor Opens Mövenpick Resort Waverly Phu Quoc  Saving the Elephants of Thailand - Interview with John Roberts, GTAEF  Aviation: COVID19 Hits January Passenger Demand  Aman to Launch New Hotel Brand  SITA Looks at How 5G Will Help to Transform Airports  COVID19: Finnair Makes Major Changes to Network and Resources  Air Cargo Demand Down 3.3% in January  British Airways Trials Autonomous Electric Mobility Devices at JFK  American Express GBT Appoints Mike Qualantone as Chief Revenue Officer  Thai Airways Extends Ticket Change Fee Waiver to More Flights  SilkAir to Suspend Hiroshima Flights Indefinitely  FlyArystan to Launch 8 Routes from New Karaganda Base  Aerobility to Expand Fleet with Former MOD Vigilant T1 Gliders  CWT Appoints David Pitts as VP Revenue and Global Supplier Management  COVID19: British Airways Launches Book with Confidence Policy  Bombardier Offers 4G In-Cabin Wi-Fi as Retrofit on Learjet Aircraft  Thai Airways Reports 2019 Operating Results  Universal Avionics' ClearVision EFVS with SkyLens HWD Certified by EASA  Minor to Operate Clinique La Prairie's First Medical Spa Outside of Europe  Royal Thai Navy Wins Elephant Boat Race for Second Year  IATA Requests Global Suspension of Slot Rules Due to COVID19 Outbreak  Air Astana Takes Delivery of Second Airbus A321LR  Vistara Expands Partnership with Sabre  Shinta Mani Wild Appoints Tim Pheak as Executive Chef  Aeroflot Takes Delivery of First Airbus A350  Vietnam Airlines to Suspend All Flights to South Korea  Pictures from Elephant Boat Race and Bangkok River Festival 2020  Accor Opens Second ibis Styles Hotel in Vietnam  AirAsia Thailand Receives IOSA Certification  Travelport Achieves Level 4 NDC Aggregator Certification  Qatar Airways Opens Premium Lounge at Changi Airport  British Airways Expands NDC Offering  Steven Phillips Appointed GM of LUX* Grand Baie Resort in Mauritius  Russian Helicopters Delivers First Mi-38  Asia Pacific Airlines Carried 33.8m Int. Pax in January  Delta Reduces Seoul Flights; Delays Manila Launch  Finnair to Increase Flights to Delhi and Los Angeles  Thai Smile Becomes Second Connecting Partner of Star Alliance  ANA to Add 15 More Boeing 787 Dreamliners to Fleet  Airbus Helicopters Appoints Thomas Hundt as EVP - Finance  First Pratt & Whitney GTF Engine Produced in Japan Joins Flight Tests  Air Malta and Qatar Airways to Codeshare  Susan Doniz to Join Boeing as CIO / SVP IT and Data Analytics  AirAsia to Resume Manila - Saigon Flights; Launch Clark - Tagbilaran  COVID19: Qantas and Jetstar Make Major Changes to Network  Air Astana Changes Ticket Rules for Travellers from HK, JP, MO, SG, KR and TH  Hong Kong Int. Airport Introduces New Round of Relief Measures  Russian Helicopters to Commence Production of Ansat Aurus  Hong Kong Win Bronze at Inaugural World Rugby HSBC Sevens Challenger Series  Bangkok Airways Partners AXAThailand to Offer 'Protective Wing'  ANA to Test Autonomous Mobility Assistance at Narita Airport  Green Light for MotoGP in Buri Ram, Thailand  Aviation: COVID19 Cuts Demand and Revenues  Martin Dell Returns Home as GM of Four Seasons Hotel Prague  SWISS Takes Delivery of First A320neo  Sabre's Sean Menke to Participate in Keynote Interview at ITB Berlin  Executive Appointments at Outrigger Hospitality  CWT Appoints Linda Creighton as Vice President - Business Finance  Hilton to Open Garden Inn Hotel at Adventure Parc Snowdonia, North Wales  AirAsia Philippines to Launch Flights to Zamboanga from Cebu and Clark  Swiss-Belhotel Opens First Hotel in Malaysia  Joanne Taylor Joins FCM as Director of Account Management Asia  Thai Airways Waives Fees on Japan, Korea, Singapore and Taiwan Flights  SalamAir Partners Tune Protect for Travel Insurance  American Airlines to Expand Preordered Meal Service  Etihad Airways to Launch TravelPass  AirAsia to Launch Flights from Clark and Cebu to General Santos, Philippines  MICE in North Wales - Interview with Richard Jones of venue cymru, Llandudno  Air New Zealand Extends Reduction in Flights to Hong Kong and Shanghai  Patrick de Castelbajac to Join Nordic Aviation Capital as CEO  Thai Airways Opens New Lounge at Phuket Airport  Bulgaria Air and Qatar Airways to Codeshare  Tarom Takes Delivery of First of Nine ATR 72-600s  Whitbread Signs Sixth Premier Inn Hotel in Ireland  Mandarin Oriental Jumeira Dubai Opens Royal Penthouse  COVID19: Zero Risk and Travel Advisories - Where Do We Stop?  Campbell Wilson to Rejoin Scoot as CEO  MIAT to Implement Sabre's Global Demand Data Solution  Cathay Pacific Carried 3M Pax in Jan; Reduces Flight Capacity by 40%  Roger Brantsma Joins 825-Room Hilton Tokyo as General Manger  Thai Airways Increases Passenger Screening on Flights from Cambodia  Mandarin Oriental Boston to Complete US$ 15 Million Renovation in April  Erica Antony Joins CWT as Chief Product Officer  Bjoern van den Oever Joins Alila Villas Koh Russey as Executive Chef  Unicorn Hospitality Opens 47-Room Hotel in Bangkok, Thailand  Hong Kong Airport Handled 5.7 Million Passengers in January  Vietnam Airlines Adds Wide-Body Aircraft to Hanoi - Saigon Route  Pratt & Whitney GTF Engines to Power Korean Air's New A321neos  AsBAA Appoints Jeff Chiang as Chief Operating Officer  Psychometrics at Naruna Retreats in Cambodia, Laos, Myanmar and Thailand  Airbus A330-800 Receives Type Certification from EASA and FAA  Hamza Sehili Joins Four Seasons Tunis as Hotel Manager  British Airways and Royal Air Maroc to Codeshare  Green Africa Airways Signs MOU for 50 Airbus A220-300s  Hong Kong Visitor Arrivals Plummet to Below 3,000 Per Day  What Does Tourism Mean to Conwy, North Wales? Interview with Mayor  Thai Airways Launches Promotion for Royal Orchid Plus Members  Dusit Thani Abu Dhabi Upgrades Rooms and MICE Facilities  FlyArystan to Launch New Routes, Expand Capacity from Almaty, Kazakhstan  Finnair Extends Suspension of Flights to China; Reduces HK Service  SAS Extends Suspension of Flights to China  Air Astana to Launch Flights to Mumbai, India  HK7s and Singapore Sevens Rescheduled  Quay Hotel & Spa in Deganwy, North Wales - Interview with Brid Collins  Royal Thai Air Force Orders Six Airbus H135 Helicopters  CWT Appoints Laura Watterson as SVP - Global Talent & Rewards  Yee Pin Tan Joins Six Senses as Head of Design  Boeing Forecasts Southeast Asia to Need 4,500 New Airplanes Over Next 20 Years  Bombardier Completes Strategic Exit from Commercial Aviation  British Airways to Launch Flights Between London Heathrow and Newquay  Six Senses Appoints Bryan Gabriel as CCO  Piotr Madej Joins The Andaman Langkawi as GM  Sustainable Inspiration from Farmer Gareth Wyn Jones in North Wales  PNG Air Orders Three ATR 42-600S Aircraft  Japan Airlines Joins Amadeus NDC Program  BBAM to Convert Three Boeing 737-800s into Freighters  John Woolley Joins The Ritz-Carlton Bali as GM  French Navy to Operate Four Airbus H160 Helicopters  British Airways Extends Suspension of Flights to Beijing and Shanghai  Air France Extends Suspension of Flights to Beijing and Shanghai  Welsh Wine from the Gwinllan Conwy Vineyard - Interview with Colin Bennett  Vietjet to Launch Three New Routes to India  WTTC's 20th Global Summit to Take Place 22-23 April in Cancun, Mexico  Keio Plaza Hotel Tokyo to Open Renovated Rooms on 29 March  2019-nCoV - Arbitrary Restrictions and Blanket Travel Bans Cause Confusion  China and Mandarin Airlines Make Further Changes to Cross-Strait Services  Premier Inn to Add 735 Beds to Scotland Portfolio in 2020  Valentino Longo Wins North America's Most Imaginative Bartender Competition  Aviation: Slower But Steady Growth in 2019  Phuket to Host Thailand Travel Mart (TTM+) 2020 in June  Thailand: Did Strength of Thai Baht Affect Number of Arrivals from UK in 2019?  Seaplanes in Thailand? Interview with Dennis Keller, CBO of Siam Seaplane  Future of Airline Distribution and NDC - Interview with Yanik Hoyles, IATA  Cambodia Airways Interview with Lucian Hsing, Commercial Director  HD Videos and Interviews  Podcasts from HD Video Interviews  Travel Trade Shows in 2019, 2020 and 2021  High-Res Picture Galleries  Travel News Asia - Latest Travel Industry News  Read the full article

[victorparker1-blog]

Isoray (ISR) Stock: Circles Back Toward Leadership Position In Treating Prostate Cancer

If an investor pitched me on all of the positive features of IsoRay, Inc. (NYSEAMERICAN: ISR) and told me at the end of the presentation that the stock was selling for just 0.45 cents, I would ask him where I could back up the truck to load up on shares. After all, Isoray is a revenue producing company, has assembled an experienced and efficient management team, and is continuing its potentially disruptive cancer treatment using Cesium-131, the Company’s cancer fighting isotope that is currently used to treat a broad range of cancers.

Acknowledging that the oncology treatment sector usually follows the money and offers treatments that may provide the highest revenue stream, it’s a bit easier to understand why ISR might have fallen off an investor’s radar during the past few years. But, now that the industry and treatment demands are changing once again, ISR is newly positioned to take swift advantage of treating patients with prostate cancer, the company’s primary focus at the moment. However, Cesium-131 brachytherapy is likely to expand into the treatment of both brain and head and neck cancers in the relative near term.

Moving forward, science and long-term data is proving that the use of Cesium-131 to treat cancer patients has come full circle, starting to replace therapies that rely on radioactive iodine and palladium that take a lot longer to treat prostate cancer patients and do not have optimal properties to treat more aggressive cancers.  

For ISR and Cesium-131, the timing of the changes may be an opportune moment for Isoray to capitalize on its fourteen years of experience with the isotope, with a significant ten-year patient data set that supports the efficacy of the product.

Cesium-131 Is A Disruptive And Effective Isotope

Cesium-131 is not a new concept in targeting cancers. For more than fourteen years, Isoray has continued its development of this unique isotope, proving its targeted benefits in over 11,000 patients that have various cancer indications. In brain cancer, the results show the ability to provide localized control in more than 80% of the patients, while substantially reducing radiation exposure to uninvolved brain tissue and minimal effect on patients’ continued cognitive abilities. But, the benefits go well beyond safety. Cesium-131 can be used as a second line treatment after the maximum radiation is dosed to a patient, providing long-term beneficial effects and may give the company a lucrative opportunity to expand its use in multiple cancer indications.

However, as strong as Cesium-131 might be, the fact that ISR is the only company able to produce “seeds” using this promising isotope makes the case and position for Isoray that much stronger. For those new to the Cesium-131 isotope, it’s important to know that there is already a fourteen -year history of clinical data and patient use. And, now that encouraging five, seven, and longer term data is getting published, the results are emerging as to why this treatment may become a potential first-line approach to treat both prostate and brain cancers.

Cesium-131 is proving its worth to replace radiative iodine and palladium, both of which are shown to take long periods of time to administer their radiation dose due to their radioactive half-lives being considerably longer than Cesium-131, thereby prolonging the therapeutic time required for the radiation treatment in patients and often prolonging the lengthy and uncomfortable side effects from radiation as well.  At this juncture, the patient population and its oncology practitioners may begin to once again look to Cesium-131 as a quickly administered treatment that may significantly reduce the time course of the side effects of high-dose radiation therapy.

The oncology industry tends to follow the money, and for patients, this means they sometimes get the treatment that generates a higher reimbursement rate for practitioners, regardless of other factors related to patient outcomes. That might be a harsh statement to believe, but, a quick historical snapshot may indicate that Cesium-131 should have never left the front of the pack for treatment options, despite the money made through other options.

Two Decades Later, It’s A Return To Cesium-131

In the early 1990’s, for instance, patients were primarily treated with surgery and now outdated radiation therapy. The introduction of brachytherapy in that same period boosted the hopes of many prostate cancer patients, introducing  a much less invasive, out-patient treatment option that implanted permanent seeds to target cancer with great reported success. This evolution was timely, especially when more than 150,000 patients diagnosed with prostate cancer had to undergo complete prostate removal, which led to scores of adverse side effects and life-altering challenges. The addition of brachytherapy was disruptive and a significant step forward, and brought in big players like GE Medical and Johnson and Johnson. But, in the early part of the next decade, that technology took a back seat to even newer technology –the next generation of external beam radiation.

Like brachytherapy, the external beam radiation was a less invasive treatment option over other standards of care such as surgical removal of the prostate gland. But the process took upwards of seven weeks to apply and appeared to be more attractive to oncologists because of its high reimbursement rate rather than its long-term effectiveness. To be clear, medical professionals need not get criticized for using a particular treatment option available to them, but, data shows that preferred methods to treat often follow the money, and the external beam was a money maker at the time.

Now, with the long-term data of Cesium-131 making its way to market, and peer-reviewed publications showing support, ISR is positioned to benefit from many strategic maneuvers made at the company over the prior two years. With a revamped sales and management team in place, the company’s infrastructure is already built to withstand far higher revenue streams that will not require a substantial increase in its SG&A expenditures. In fact, analysts have commented on their belief that ISR, with its current management and sales team in place, can generate upwards of $50 million in revenue, enjoy much healthier margins, and would not be at risk to jeopardize the economies of scale that are now in place at the Company.

Cesium-131 Benefits Is First-Line Worthy

Proven to have a far shorter half-life and higher energy than other regularly used implantable radioisotopes, Cesium-131 brachytherapy is demonstrating its ability be highly effective in treating cancer, along with the advantages of fewer side effects and quicker recovery times. In addition to those benefits, the treatment can be personalized to the individual patient to provide a higher concentration of radioactive therapy to the cancer, and at the same time significantly reduce unintended spillover of excess radiation to healthy cells and organs.

With over five years of data supporting its merits, Cesium-131 can become a disruptive treatment option for patients with prostate, brain, and other types of cancers. The data, collected by multiple institutions and reported in peer-reviewed journal publications, supports the thesis that Cesium-131 provides excellent local control of treatment and offers a significant quality of life enhancement to patients versus competing therapies. Recently published prostate cancer results suggest a quality of life improvement over competitive implantable isotopes as well. With these results, Isoray is active in seeking increased reimbursement rates from providers for surgical procedures that can offer a springboard of opportunity to the company.

Further, the company is pursuing additional reimbursement for its non-prostate applications.  There is a pending application for a new payment for brain brachytherapy treatment that if accepted, will make it easier for clinicians to offer this innovative new treatment.

Now, a little over a decade since its introduction, Cesium-131 is getting called out as the “next generation” of cancer treatment that holds the ability to change the way patients get treated.

The Next Generation Of An Established Cesium-131

Providing a faster and more consistent treatment option for patients, Cesium-131 is getting called the “next-generation” of brachytherapy isotope therapy. Supported by a decade worth of clinical data that shows Cesium-131 as having the ability to deliver a highly targeted dose of intense radiation therapy treatment without unnecessary radiation dosing to surrounding tissue, the isotope is gaining new attention.

Far removed from lengthy and often uncomfortable dosing regimens, Cesium-131 is delivered in a single-session treatment, avoiding the 6-8 weeks usually associated with external radiation treatment. And, with its high efficacy, ISR is positioned to take advantage of the more than $9.3 billion radiation therapy market that is projected by 2024.

In fact, clinical indications show that Cesium-131 is already a better option. Data shows the product to have a much shorter half-life and is a higher energy low dose rate (LDR) isotope that aggressively attacks cancer. Importantly, the treatment has limited impact on surrounding tissues and much faster radiation disposition for aggressive cancers.

And, while the sector tends to follow the money, Cesium-131 may provide a cost-effective and patient-friendly approach to patients who can benefit from a single treatment session. In doing so, patients can avoid invasive surgeries and instead benefit from Cesium-131’s low side effect profile.

Coming full circle and enjoying significant attention and positive reviews, Isoray may be able to leverage the success in the near term.

Massive Market Potential Creates Value Opportunity

The market opportunity for Isoray is substantial, estimated to eclipse the $1 billion level for only the cancers that ISR is targeting. Prostate cancer, where ISR is heavily focused, may offer a $700 million market, followed by brain, head & neck, and other cancers adding an additional $600 million market opportunity.

Annual diagnosis of prostate cancers is expected to surpass 200,000 cases per year, with potential LDR isotope treatment given to approximately 140,000 of those patients. Brain tumors account for more than 100,000 new cases per year, while head and neck, and other addressable cancers account for roughly 240,000 new cases per year for those indications. The opportunity can be global for ISR, and with Cesium-131 proving to be a potentially best-in-class treatment option, a significant reflection of value may be missing from the company’s current market cap.

While the LDR isotope market offers substantial opportunity, the growing opportunity in the brachytherapy market can be equally as impressive an opportunity. Brachytherapy is proven in randomized clinical trials to demonstrate significant therapeutic advantages in high-risk patients. And, where new data shows that competing therapies are not meeting their intended expectations, Isoray’s treatment option stands out even further and can generate an expected $150 million of potential revenues where ISR currently holds only 3% of the share. Thus, as management continues to move the company forward, a market of more than 25,000 annual prostate brachytherapy procedures may offer substantial near-term opportunities for ISR to generate meaningful and long-term revenue streams.

The Opportunity For This Disruptive Isotope Gets Better

Here is where the opportunity gets even better for both ISR and its investors. First, there is no clear market leader in the small brachytherapy space, and many of the existing companies have reduced sales forces and an IP portfolio that is inferior to Cesium-131. Additionally, the market is consolidating, and fewer companies are concentrating on better treatments to target prostate cancer, a specific focus for Isoray. Banking on its low toxicity rate and clinical evidence to support the benefits of Cesium-131, ISR may benefit significantly from their increased investment in the prostate cancer market.

On the topic of brain cancer, Isoray’s isotope platform has received support from multiple publications from Weill Cornell Medical College, which showed high rates of brain cancer control when Cesium-131 brachytherapy is used in combination with surgery. The company is also part of a collaborative partnership with GammaTile to develop and commercialize a custom brachytherapy delivery system for treatment of Brain Cancer.  The GammaTile product has treated over 100 patients as part of an approved IRB protocol at the Barrow Neurological Institute, a leading neurological disease treatment and research center which gets consistently ranked as one of the best neurological training centers in the United States.

The device is following the 510(k) regulatory pathway, and ISR expects to complete final bio-compatibility testing in the first half of 2018. The device itself is a combination of Cesium-131 seeds embedded into collagen “tiles” and placed onto the resection margin during surgery. The process adds less than ten minutes to the surgical procedure, and ISR enjoys a ten-year exclusive manufacturing agreement executed in January of 2018. The critical FDA approval process is moving forward in parallel with Medicare Reimbursement with the ICD 10 code already issued and the NTAP (New Technology Add on Payment) application in process.

To date, the use of Cesium-131 tiles shows high rates of local control of the treated tumors combined with a low rate of radiation injury, a long-time concern for patients who have undergone multiple treatments for their brain tumors.

Thus, with an ample market, supporting data, and an ongoing regulatory approval process established, Isoray is hitting on all cylinders as they gain increased market exposure and receive additional supporting data for their proprietary isotope treatment.

How Isoray Keeps Getting Better

Having a great product and a clear path for expected FDA approval of its GammaTile device is half of the measure needed to seize upon the long-term opportunity. It takes a focused strategy to deliver the goods. For ISR and its investors, the accretive benefits from its upgraded commercial team will play a key role in building further success, as it will assist in securing Cesium-131’s share with base customers and at the same time potentially increase active customers by more than 40%.

Management is also taking advantage of established marketing programs to communicate the benefits of Cesium-131 by bringing resources directly to patients through social and digital channels. Importantly, physicians are starting to contact ISR directly to initiate sales processes and to learn more about the benefits of Cesium-131 treatment.

Management is also focused on maintaining and building cost-minimizing and process improvement programs to create higher margins and quickly benefit from the installation of their manufacturing automation processes in 2017 and 2018.

Perhaps the most near-term catalyst for Isoray is to establish increased reimbursement levels and coverage of Cesium-131 in surgical procedures, and at ISR, this process that is well underway. Combining a well-built infrastructure with a potentially disruptive technology, Isoray is positioned to increase shareholder value as they execute on many strategic fronts.

Targeting prostate cancer, ISR is investing in sales and marketing, research and development, and commercialization of Cesium-131. The goal is to grab a stronger position in not only the prostate cancer market but to target and take advantage of the lucrative opportunities presented by the potential to effectively treat brain, head and neck, and gynecological cancers. The commitment to seizing this opportunity is demonstrated by ISR’s five consecutive quarters of revenue growth, supported by increased volume in both new and existing accounts. From Isoray’s perspective, they believe that they have the “right team, right isotope, right strategy.” And, based on the mountain of empirical evidence that shows Cesium-131 to be a potentially disruptive force in how specific cancers are treated, investors may be wise to agree with their assessment.

This article was featured on CNA Finance.

Research ISR

Show Tweets Mentioning ISRHide Tweets Mentioning ISRShow Tweets Mentioning ISR

check out this web site for more info on the subject of gold investment

from victorparker https://www.modestmoney.com/isoray-isr-stock-circles-back-toward-leadership-position-in-treating-prostate-cancer/41097/

[health-and-medical-services]

Healthier SG: A Holistic Approach To Singapore's Health And Wellness

Healthier SG is a national initiative that aims to shift the focus of healthcare from reactive treatment to preventive care. Instead of simply treating illnesses when they occur, Healthier SG encourages Singaporeans to take proactive steps in maintaining their health. This involves regular health check-ups, adopting healthier lifestyle habits, and managing chronic conditions more effectively. 

Health and wellness have always been a priority for Singapore’s government, and to further enhance the well-being of its citizens, the Ministry of Health introduced the Healthier SG initiative. This comprehensive program is designed to help Singaporeans lead healthier lives by focusing on preventive care, personalized health plans, and fostering a supportive community for maintaining long-term wellness. For more details, visit our website.

[health-and-medical-services]

How Does Healthier SG Help Singaporeans Lead A Healthier Lifestyle?

Discover how Healthier SG helps Singaporeans lead a healthier lifestyle by offering personalized health plans, preventive care, and access to wellness programs. This government initiative focuses on improving long-term health outcomes by encouraging regular check-ups, healthier habits, and active participation in fitness activities. With community support and accessible healthcare resources, Healthier SG empowers individuals to take control of their well-being, ensuring a healthier future for all Singaporeans. To know everything about Healthier SG, please read our full blog.

[health-and-medical-services]

Healthier SG: A Comprehensive Guide To Singapore's National Health Initiative

Healthier SG is a groundbreaking national initiative launched by the Singapore government to improve the overall health and well-being of its citizens. The program focuses on preventive care, chronic disease management, and creating a healthier society through active participation in personal health journeys. Healthier SG aims to encourage Singaporeans to adopt healthier lifestyles and engage in preventive healthcare. It’s part of the government’s long-term strategy to tackle rising healthcare costs and the increasing burden of chronic diseases like diabetes, hypertension, and heart disease. The initiative places emphasis on personalized care plans, regular health screenings, and vaccinations to improve long-term health outcomes. For more details, read our full blog.

[health-and-medical-services]

Top Benefits Of Choosing Healthier SG Clinic For Your Healthcare Needs

Discover how Healthier SG is transforming healthcare with personalized wellness plans, preventive care, and a focus on healthier living for everyone. Join the movement towards a healthier Singapore! Bookmarking your health with the right clinic is a significant step towards a healthier future. Healthier SG Clinic stands out as a top choice for many, and here’s why you should consider it for your healthcare needs. 

Comprehensive Care: Offering a wide range of services from preventive care to specialized treatments, ensuring all your healthcare needs are met under one roof. 

Experienced Professionals: Our team of highly qualified doctors and healthcare professionals bring years of expertise to provide the best care possible. 

State-of-the-Art Facilities: Equipped with the latest medical technology, we ensure accurate diagnoses and effective treatments. 

Personalized Approach: We prioritize your unique health needs and tailor our services to provide personalized care plans. 

Convenient Location: Strategically located, making it easy for you to access quality healthcare without hassle. 

Choose Healthier SG Clinic for a trusted, comprehensive, and patient-centered approach to your health. Your well-being is our priority.

[health-and-medical-services]

How Can Healthier SG Clinics Help Manage Chronic Diseases?

Chronic diseases, such as diabetes, hypertension, and heart disease, are significant health concerns worldwide. In Singapore, the prevalence of these conditions is on the rise, prompting the need for more effective healthcare solutions. Enter Healthier SG Clinics, a new initiative designed to transform the way chronic diseases are managed. These clinics aim to provide comprehensive, patient-centered care that can significantly improve the quality of life for those living with chronic conditions. Here’s how Healthier SG can make a difference.

Personalized Care Plans

Healthier SG Clinics prioritize personalized care, recognizing that each patient’s journey with chronic disease is unique. By tailoring treatment plans to individual needs, these clinics can address specific health concerns more effectively. Personalized care plans often include:

Customized medication regimens: Adjusting doses and types of medication based on patient response.

Diet and nutrition advice: Offering personalized dietary plans to manage weight and blood sugar levels.

Exercise programs: Developing physical activity routines that are safe and beneficial for each patient.

Integrated Healthcare Services

One of the key features of Healthier SG Clinics is the integration of various healthcare services under one roof. This holistic approach ensures that patients receive coordinated care, reducing the likelihood of fragmented treatment. Integrated services may include:

Primary care: Regular check-ups and management of chronic conditions.

Specialist care: Access to specialists for more complex health issues.

Mental health support: Counseling and support for mental well-being, recognizing the link between chronic diseases and mental health.

Enhanced Patient Education

Educating patients about their conditions and treatment options is crucial for effective chronic disease management. Healthier SG Clinics emphasize patient education through:

Workshops and seminars: Regular sessions on managing chronic diseases, including lifestyle modifications and self-care techniques.

One-on-one consultations: Personalized education during appointments to ensure patients understand their treatment plans.

Educational materials: Providing brochures, pamphlets, and online resources for continuous learning.

Advanced Technology and Digital Health Tools

Embracing technology is a cornerstone of Healthier SG Clinics. The use of advanced digital health tools can greatly enhance chronic disease management by:

Telemedicine services: Allowing patients to consult with healthcare providers from the comfort of their homes.

Mobile health apps: Enabling patients to track their health metrics, medication schedules, and appointments.

Electronic health records (EHRs): Facilitating seamless information sharing between different healthcare providers.

Proactive and Preventive Care

Prevention is always better than cure, and Healthier SG Clinics are committed to proactive care strategies to prevent the progression of chronic diseases. This includes:

Regular screenings: Early detection of potential health issues through routine health screenings.

Vaccinations: Keeping patients up-to-date with necessary vaccinations to prevent complications.

Lifestyle interventions: Encouraging healthy habits such as smoking cessation, balanced diets, and regular exercise.

Community Engagement and Support

Healthier SG Clinics also focus on community engagement, fostering a supportive environment for patients. Community-based initiatives can include:

Support groups: Creating networks where patients can share experiences and advice.

Community health programs: Organizing activities like health fairs, fitness classes, and nutrition workshops.

Partnerships with local organizations: Collaborating with community centers, schools, and workplaces to promote health and wellness.

Conclusion

Healthier SG Clinics represent a forward-thinking approach to managing chronic diseases. By offering personalized care plans, integrated services, enhanced patient education, advanced technology, proactive care, and community support, these clinics can significantly improve the lives of those living with chronic conditions. As Singapore continues to innovate in healthcare, the Healthier SG initiative stands as a promising model for chronic disease management, paving the way for a healthier future for all. Read our blog on how to enroll with Healthier SG

[health-and-medical-services]

Promoting Health And Wellness In Singapore With Healthier SG GP

Singapore has long been recognized for its commitment to excellence in healthcare and its proactive approach to promoting the well-being of its citizens. A cornerstone of this commitment is the Healthier SG GP program, which is an innovative and comprehensive initiative aimed at fostering health and wellness throughout the nation.

This program represents a concerted effort to engage the entire healthcare ecosystem, from patients to healthcare providers and policymakers, in the pursuit of a healthier Singapore. For more information, visit our website.

[health-and-medical-services]

Enrolling In The Healthier SG Clinic: Your Path To Optimal Wellness

Are you also the one who wants to know how to enroll in a Healthier SG clinic? Embark on a journey towards enhanced well-being by enrolling in the Healthier SG Clinic – your ultimate destination for comprehensive healthcare and personalized attention. This step-by-step guide will walk you through the process of enrolling in the clinic, highlighting the numerous benefits and services that await you. For more information, visit our website.